Kallikrein-related peptidase 6 in Alzheimer's disease and vascular dementia

Brain Research

Volumn 1363, Issue , 2010, Pages 1-10

  Ashby, Emma L ^a   Kehoe, Patrick G ^a   Love, Seth ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Alzheimer's disease; Kallikrein; Kallikrein related peptidase 6 human; KLK6 protein human; Vascular dementia

Indexed keywords

KALLIKREIN 6; MESSENGER RNA;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MULTIINFARCT DEMENTIA; NEOCORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TEMPORAL CORTEX; WHITE MATTER;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CEREBRAL CORTEX; DEMENTIA, VASCULAR; ENDOTHELIAL CELLS; FACTOR VIII; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FRONTAL LOBE; HUMANS; KALLIKREINS; MALE; MIDDLE AGED; NEOCORTEX; NEURONS; RNA, MESSENGER; TEMPORAL LOBE;

EID: 78149468228     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.09.017     Document Type: Article

References (54)

1. P.F. Angelo, A.R. Lima, F.M. Alves, S.I. Blaber, I.A. Scarisbrick, M. Blaber, L. Juliano, and M.A. Juliano Substrate specificity of human kallikrein 6: salt and glycosaminoglycan activation effects J. Biol. Chem. 281 2006 3116 3126
2. A. Anisowicz, G. Sotiropoulou, G. Stenman, S.C. Mok, and R. Sager A novel protease homolog differentially expressed in breast and ovarian cancer Mol. Med. 2 1996 624 636
3. S. Baig, G.K. Wilcock, and S. Love Loss of perineuronal net N-acetylgalactosamine in Alzheimer's disease Acta Neuropathol. 110 2005 393 401
4. M.J. Bernett, S.I. Blaber, I.A. Scarisbrick, P. Dhanarajan, S.M. Thompson, and M. Blaber Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system J. Biol. Chem. 277 2002 24562 24570
5. J.V. Bowler, and P.B. Gorelick Advances in vascular cognitive impairment Stroke 40 2009 e315 e318
6. H. Braak, E. Braak, and J. Bohl Staging of Alzheimer-related cortical destruction Eur. Neurol. 33 1993 403 408
7. F.C. Bronfman, J. Garrido, A. Alvarez, C. Morgan, and N.C. Inestrosa Laminin inhibits amyloid-beta-peptide fibrillation Neurosci. Lett. 218 1996 201 203
8. L. Buee, P.R. Hof, C. Bouras, A. Delacourte, D.P. Perl, J.H. Morrison, and H.M. Fillit Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders Acta Neuropathol. (Berl) 87 1994 469 480
9. O. Bukalo, M. Schachner, and A. Dityatev Modification of extracellular matrix by enzymatic removal of chondroitin sulfate and by lack of tenascin-R differentially affects several forms of synaptic plasticity in the hippocampus Neuroscience 104 2001 359 369
10. S.A. Bustin Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems J. Mol. Endocrinol. 29 2002 23 39
11. E.P. Diamandis, G.M. Yousef, L.Y. Luo, A. Magklara, and C.V. Obiezu The new human kallikrein gene family: implications in carcinogenesis Trends Endocrinol. Metab. 11 2000 54 60
12. E.P. Diamandis, G.M. Yousef, C. Petraki, and A.R. Soosaipillai Human kallikrein 6 as a biomarker of Alzheimer's disease Clin. Biochem. 33 2000 663 667
13. E.P. Diamandis, G.M. Yousef, A.R. Soosaipillai, and P. Bunting Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma Clin. Biochem. 33 2000 579 583
14. B. Drouet, M. Pincon-Raymond, J. Chambaz, and T. Pillot Laminin 1 attenuates beta-amyloid peptide Abeta(1-40) neurotoxicity of cultured fetal rat cortical neurons J. Neurochem. 73 1999 742 749
15. C.P. Ferri, M. Prince, C. Brayne, H. Brodaty, L. Fratiglioni, M. Ganguli, K. Hall, K. Hasegawa, H. Hendrie, Y. Huang, A. Jorm, C. Mathers, P.R. Menezes, E. Rimmer, and M. Scazufca Global prevalence of dementia: a Delphi consensus study Lancet 366 2005 2112 2117
16. T. Fraser, H. Tayler, and S. Love Low-temperature improved-throughput method for analysis of brain fatty acids and assessment of their post-mortem stability J. Neurosci. Methods. 169 2008 135 140
17. M.C. Ghosh, L. Grass, A. Soosaipillai, G. Sotiropoulou, and E.P. Diamandis Human kallikrein 6 degrades extracellular matrix proteins and may enhance the metastatic potential of tumour cells Tumour Biol. 25 2004 193 199
18. R.N. Kalaria, G.E. Maestre, R. Arizaga, R.P. Friedland, D. Galasko, K. Hall, J.A. Luchsinger, A. Ogunniyi, E.K. Perry, F. Potocnik, M. Prince, R. Stewart, A. Wimo, Z.X. Zhang, and P. Antuono Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors Lancet Neurol. 7 2008 812 826
19. A. Kalinowska, and J. Losy PECAM-1, a key player in neuroinflammation Eur. J. Neurol. 13 2006 1284 1290
20. S.P. Little, E.P. Dixon, F. Norris, W. Buckley, G.W. Becker, M. Johnson, J.R. Dobbins, T. Wyrick, J.R. Miller, W. MacKellar, D. Hepburn, J. Corvalan, D. McClure, X. Liu, D. Stephenson, J. Clemens, and E.M. Johnstone Zyme, a novel and potentially amyloidogenic enzyme cDNA isolated from Alzheimer's disease brain J. Biol. Chem. 272 1997 25135 25142
21. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(- Delta Delta C(T)) Method Methods 25 2001 402 408
22. A. Lundwall, and M. Brattsand Kallikrein-related peptidases Cell. Mol. Life Sci. 65 2008 2019 2038
23. A. Magklara, A.A. Mellati, G.A. Wasney, S.P. Little, G. Sotiropoulou, G.W. Becker, and E.P. Diamandis Characterization of the enzymatic activity of human kallikrein 6: autoactivation, substrate specificity, and regulation by inhibitors Biochem. Biophys. Res. Commun. 307 2003 948 955
24. M. Menendez-Gonzalez, P. Castro-Santos, A. Suarez, M.T. Calatayud, P. Perez-Pinera, M. Martinez, R. Ribacoba, and C. Gutierrez Value of measuring plasmatic levels of neurosin in the diagnosis of Alzheimer's disease J. Alzheimers Dis. 14 2008 59 67
25. S.S. Mirra, A. Heyman, D. McKeel, S.M. Sumi, B.J. Crain, L.M. Brownlee, F.S. Vogel, J.P. Hughes, G. van Belle, and L. Berg The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease Neurology 41 1991 479 486
26. S. Mitsui, A. Okui, H. Uemura, T. Mizuno, T. Yamada, Y. Yamamura, and N. Yamaguchi Decreased cerebrospinal fluid levels of neurosin (KLK6), an aging-related protease, as a possible new risk factor for Alzheimer's disease Ann. NY Acad. Sci. 977 2002 216 223
27. F. Noorbakhsh, N. Vergnolle, J.C. McArthur, C. Silva, M. Vodjgani, P. Andrade-Gordon, M.D. Hollenberg, and C. Power Proteinase-activated receptor-2 induction by neuroinflammation prevents neuronal death during HIV infection J. Immunol. 174 2005 7320 7329
28. J.T. O'Brien, T. Erkinjuntti, B. Reisberg, G. Roman, T. Sawada, L. Pantoni, J.V. Bowler, C. Ballard, C. DeCarli, P.B. Gorelick, K. Rockwood, A. Burns, S. Gauthier, and S.T. DeKosky Vascular cognitive impairment Lancet Neurol. 2 2003 89 98
29. K. Ogawa, T. Yamada, Y. Tsujioka, J. Taguchi, M. Takahashi, Y. Tsuboi, Y. Fujino, M. Nakajima, T. Yamamoto, H. Akatsu, S. Mitsui, and N. Yamaguchi Localization of a novel type trypsin-like serine protease, neurosin, in brain tissues of Alzheimer's disease and Parkinson's disease Psychiatry Clin. Neurosci. 54 2000 419 426
30. K. Oikonomopoulou, K.K. Hansen, M. Saifeddine, N. Vergnolle, I. Tea, M. Blaber, S.I. Blaber, I. Scarisbrick, E.P. Diamandis, and M.D. Hollenberg Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs) Biol. Chem. 387 2006 817 824
31. C.D. Petraki, V.N. Karavana, P.T. Skoufogiannis, S.P. Little, D.J. Howarth, G.M. Yousef, and E.P. Diamandis The spectrum of human kallikrein 6 (zyme/protease M/neurosin) expression in human tissues as assessed by immunohistochemistry J. Histochem. Cytochem. 49 2001 1431 1441
32. G.C. Roman Facts, myths, and controversies in vascular dementia J. Neurol. Sci. 226 2004 49 52
33. A.K. Saghatelyan, A. Dityatev, S. Schmidt, T. Schuster, U. Bartsch, and M. Schachner Reduced perisomatic inhibition, increased excitatory transmission, and impaired long-term potentiation in mice deficient for the extracellular matrix glycoprotein tenascin-R Mol. Cell. Neurosci. 17 2001 226 240
34. I.A. Scarisbrick, P.J. Isackson, B. Ciric, A.J. Windebank, and M. Rodriguez MSP, a trypsin-like serine protease, is abundantly expressed in the human nervous system J. Comp. Neurol. 431 2001 347 361
35. G.M. Shankar, S. Li, T.H. Mehta, A. Garcia-Munoz, N.E. Shepardson, I. Smith, F.M. Brett, M.A. Farrell, M.J. Rowan, C.A. Lemere, C.M. Regan, D.M. Walsh, B.L. Sabatini, and D.J. Selkoe Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory Nat. Med. 14 2008 837 842
36. J.L. Shaw, and E.P. Diamandis Distribution of 15 human kallikreins in tissues and biological fluids Clin. Chem. 53 2007 1423 1432
37. C. Shimizu-Okabe, G.M. Yousef, E.P. Diamandis, S. Yoshida, S. Shiosaka, and M. Fahnestock Expression of the kallikrein gene family in normal and Alzheimer's disease brain NeuroReport 12 2001 2747 2751
38. D.H. Small, V. Nurcombe, H. Clarris, K. Beyreuther, and C.L. Masters The role of extracellular matrix in the processing of the amyloid protein precursor of Alzheimer's disease Ann. NY Acad. Sci. 695 1993 169 174
39. V.L. Smith-Swintosky, C.T. Cheo-Isaacs, M.R. D'Andrea, R.J. Santulli, A.L. Darrow, and P. Andrade-Gordon Protease-activated receptor-2 (PAR-2) is present in the rat hippocampus and is associated with neurodegeneration J. Neurochem. 69 1997 1890 1896
40. G. Sotiropoulou, G. Pampalakis, and E.P. Diamandis Functional roles of human kallikrein-related peptidases J. Biol. Chem. 2009
41. F. Striggow, M. Riek-Burchardt, A. Kiesel, W. Schmidt, P. Henrich-Noack, J. Breder, M. Krug, K.G. Reymann, and G. Reiser Four different types of protease-activated receptors are widely expressed in the brain and are up-regulated in hippocampus by severe ischemia Eur. J. Neurosci. 14 2001 595 608
42. W.G. Tatton, R.M. Chalmers-Redman, M. Elstner, W. Leesch, F.B. Jagodzinski, D.P. Stupak, M.M. Sugrue, and N.A. Tatton Glyceraldehyde-3- phosphate dehydrogenase in neurodegeneration and apoptosis signaling J. Neural Transm. Suppl. 2000 77 100
43. Z. van Helmond, K. Heesom, and S. Love Characterisation of two antibodies to oligomeric Abeta and their use in ELISAs on human brain tissue homogenates J Neurosci Methods. 176 2009 206 212
44. Z.K. van Helmond, J.S. Miners, E. Bednall, K.A. Chalmers, Y. Zhang, G.K. Wilcock, S. Love, and P.G. Kehoe Caveolin-1 and -2 and their relationship to cerebral amyloid angiopathy in Alzheimer's disease Neuropathol. Appl. Neurobiol. 33 2007 317 327
45. A.G. Vandell, N. Larson, G. Laxmikanthan, M. Panos, S.I. Blaber, M. Blaber, and I.A. Scarisbrick Protease activated receptor dependent and independent signaling by Kallikreins 1 and 6 in CNS neuron and astroglial cell lines J. Neurochem. 2008
46. A. Woodfin, M.B. Voisin, and S. Nourshargh PECAM-1: a multi-functional molecule in inflammation and vascular biology Arterioscler. Thromb. Vasc. Biol. 27 2007 2514 2523
47. Z. Wu, H. Guo, N. Chow, J. Sallstrom, R.D. Bell, R. Deane, A.I. Brooks, S. Kanagala, A. Rubio, A. Sagare, D. Liu, F. Li, D. Armstrong, T. Gasiewicz, R. Zidovetzki, X. Song, F. Hofman, and B.V. Zlokovic Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease Nat. Med. 11 2005 959 965
48. K. Yamashiro, N. Tsuruoka, S. Kodama, M. Tsujimoto, Y. Yamamura, T. Tanaka, H. Nakazato, and N. Yamaguchi Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain Biochim. Biophys. Acta 1350 1997 11 14
49. U.S. Yezhuvath, J. Uh, Y. Cheng, K. Martin-Cook, M. Weiner, R. Diaz-Arrastia, M. van Osch, H. Lu, U.S. Yezhuvath, J. Uh, Y. Cheng, K. Martin-Cook, M. Weiner, R. Diaz-Arrastia, M. van Osch, and H. Lu Forebrain-dominant deficit in cerebrovascular reactivity in Alzheimer's disease Neurobiol. Aging 2010
50. G.M. Yousef, and E.P. Diamandis The new kallikrein-like gene, KLK-L2. Molecular characterization, mapping, tissue expression, and hormonal regulation J. Biol. Chem. 274 1999 37511 37516
51. G.M. Yousef, L.Y. Luo, S.W. Scherer, G. Sotiropoulou, and E.P. Diamandis Molecular characterization of zyme/protease M/neurosin (PRSS9), a hormonally regulated kallikrein-like serine protease Genomics 62 1999 251 259
52. G.M. Yousef, A. Chang, A. Scorilas, and E.P. Diamandis Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4 Biochem. Biophys. Res. Commun. 276 2000 125 133
53. G.M. Yousef, and E.P. Diamandis The new human tissue kallikrein gene family: structure, function, and association to disease Endocr. Rev. 22 2001 184 204
54. M. Zarghooni, A. Soosaipillai, L. Grass, A. Scorilas, N. Mirazimi, and E.P. Diamandis Decreased concentration of human kallikrein 6 in brain extracts of Alzheimer's disease patients Clin. Biochem. 35 2002 225 231